HOME >> MEDICINE >> NEWS
12-year-old Oregon girl is first child to receive new bone growth material in her skull

aniosynostosis that fused the bones in her skull and Pfeiffer Syndrome which caused her face to recess and her ear canals to close off with skin covering them.

When Emily was six years old pieces of her skull disintegrated as a result of an infection, possibly related to a previous surgery to move the bones in her mid-face forward. The infection left Emily with large gaps in the front section of her skull. Now Emily wears a bike helmet to protect her skull where there is no bone structure.

Jeffery O. Hollinger, D.D.S., Ph.D., OHSU department of surgery (plastic and reconstructive surgery), and Seyfer have collaborated together for more than 15 years to pioneer the use and development of BMP. Hollinger and his team have received three National Institutes of Health grants totaling more than 5 million dollars to study BMP and other tissue-engineered treatments, with additional funding provided by Genetics Institutes, a company that produces and owns the patents for genetically engineered BMP.

Hollinger has pioneered tissue-engineering strategies that involve recombinant technology and polymer matrixes to regenerate bone deficiencies from developmental deformity, traumatic loss and resective procedures.

Physicians hope to use BMPs to restore shattered bones, osteoporotic fractures and cartilage degeneration. Currently, banked bones from cadavers, medical ceramics and artificial materials are used to replace missing or disfigured bones.


'"/>

Contact: Christine Long
longc@ohsu.edu
503-494-8231
Oregon Health & Science University
26-Aug-1999


Page: 1 2

Related medicine news :

1. Micro nano breakthrough conference planned for Portland, Oregon
2. OHSU researcher co-authors National State-By-State Report Card on women and smoking; Oregon flunks
3. Oregon State chemist wins national award for synthesizing molecules in nature
4. Oregon Health Sciences University Researchers track long-term results of chemotherapy assisted by blood-brain barrier disruption
5. Oregon Health Sciences University researchers study benefits of treatments offered within hours of a stroke
6. Lower death rate in Oregon hospitals linked to better care
7. One of first bone marrow transplants for juvenile rheumatoid arthritis in the United States is approved for Oregon girl
8. Oregon Health Sciences University, Portland, Oregon receives $6.5 million to fund studies on health of adolescents and firefighters
9. Oregons Terminally Ill Patients More Likely to Have End-Of-Life Choices Respected, Study Finds
10. Oregon Health Sciences University Researcher Presents Results Of Clinical Trials Of Possible Stroke-Fighting Drug
11. Researchers search for first sign of congestive heart failure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: year old Oregon girl first child receive new bone growth material her skull

(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: